EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Prolactin in high‐metabolic risk pregnancies: Associations with maternal obesity and metabolic health

Kate Rassie iD, Simon Alesi iD, Adriana C H Neven, Taitum Mason iD, Eveline Jona, Stacey J Ellery iD, Joanne Enticott iD, Aya Mousa iD, Anju E Joham iD, David Simmons iD, Helena Teede iD, TOBOGM Core Investigator Group

Acta Obstetricia et Gynecologica Scandinavica · 2026-08 · 105 (8) · 1490-1501

DOI: 10.1111/aogs.70248 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 19.05.2026. Verfasst von Kate Rassie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Monash Centre for Health Research and Implementation (MCHRI), Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victori…. Hauptthemen laut MEDLINE: Prolactin, Diabetes, Gestational, Pregnancy in Obesity, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Low prolactin levels during pregnancy have been linked to adverse maternal metabolic health. We examined pregnancy prolactin levels in relation to maternal metabolic characteristics within an ethnically diverse cohort at high metabolic risk. Material and Methods In this observational cohort study, pregnant women ( n = 130) with metabolic risk factors were characterized in early pregnancy, with sampling of serum prolactin and metabolic parameters. Fifty‐four women with gestational diabetes consented to serial profiling across pregnancy. Univariable and multivariable simple and mixed‐effects regression models examined relationships between prolactin and maternal variables.

Results

Women with obesity (BMI ≥30 kg/m 2 ) had lower early pregnancy prolactin levels than women without obesity (35.1 vs 44.3 μg/L, p = 0.03). Lower prolactin in early pregnancy was associated with higher parity and higher early pregnancy BMI, fasting insulin, insulin resistance, and diastolic blood pressure, but only relationships with parity and BMI persisted after adjustment for covariates. In the serially sampled cohort, lower prolactin levels across pregnancy were independently associated with higher pre‐pregnancy maternal BMI (adjusted β = −3.25, p = 0.04). Lower absolute prolactin increment from early to late pregnancy was independently associated with higher pre‐pregnancy and early pregnancy maternal BMI ( p = 0.046 and p = 0.04, respectively).

Conclusions

Maternal metabolic status, particularly higher BMI before and during early pregnancy, was associated with lower prolactin levels in early pregnancy and across gestation, and a smaller prolactin increase over pregnancy. Lower prolactin levels may reflect underlying metabolic health and may be relevant to the suboptimal lactation outcomes observed in women with obesity and metabolic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProlactinDiabetes, GestationalPregnancy in ObesityObesityHumansFemalePregnancyAdultBody Mass IndexCohort StudiesRisk FactorsInsulin Resistance

Stichwörter der Autor:innen

breastfeedinggestational diabeteslactationobesitypolycystic ovary syndromepregnancy in obesityprolactin

Substanzen

Prolactin

Autor:innen und Institutionen

  • Monash Centre for Health Research and Implementation (MCHRI), Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Department of Diabetes, Monash Health, Melbourne, Victoria, Australia.
  • The Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria, Australia.
  • School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.

ORCID-Profile: Kate Rassie, Simon Alesi, Taitum Mason, Stacey J Ellery, Joanne Enticott, Aya Mousa, Anju E Joham, David Simmons, Helena Teede

Zitieren

APA

Rassie, K., Alesi, S., Neven, A. C. H., Mason, T., Jona, E., Ellery, S. J., Enticott, J., Mousa, A., Joham, A. E., Simmons, D., Teede, H., & TOBOGM Core Investigator Group (2026). Prolactin in high‐metabolic risk pregnancies: Associations with maternal obesity and metabolic health. Acta Obstetricia et Gynecologica Scandinavica, 105(8), 1490-1501. https://doi.org/10.1111/aogs.70248

Vancouver

Rassie K, Alesi S, Neven ACH, Mason T, Jona E, Ellery SJ, et al. Prolactin in high‐metabolic risk pregnancies: Associations with maternal obesity and metabolic health. Acta Obstetricia et Gynecologica Scandinavica. 2026;105(8):1490-1501. doi:10.1111/aogs.70248

BibTeX
@article{Rassie2026,
  author = {Rassie, Kate and Alesi, Simon and Neven, Adriana C H and Mason, Taitum and Jona, Eveline and Ellery, Stacey J and Enticott, Joanne and Mousa, Aya and Joham, Anju E and Simmons, David and Teede, Helena and TOBOGM Core Investigator Group, TOBOGM Core Investigator Group},
  title = {Prolactin in high‐metabolic risk pregnancies: Associations with maternal obesity and metabolic health},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  volume = {105},
  number = {8},
  pages = {1490--1501},
  doi = {10.1111/aogs.70248}
}
Kostenlos starten →